APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 262 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,755,046 | +6.8% | 30,242 | -22.7% | 1.26% | -40.0% |
| Q1 2023 | $2,579,762 | +27.6% | 39,111 | 0.0% | 2.10% | +74.9% |
| Q4 2022 | $2,022,430 | -44.7% | 39,111 | -27.0% | 1.20% | -42.5% |
| Q3 2022 | $3,657,000 | +75.3% | 53,542 | +16.0% | 2.09% | +65.9% |
| Q2 2022 | $2,086,000 | +11.3% | 46,141 | +25.1% | 1.26% | +5.6% |
| Q1 2022 | $1,875,000 | +188.0% | 36,893 | +86.7% | 1.19% | +176.6% |
| Q3 2021 | $651,000 | – | 19,763 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |